Also published on: XIV SO 2020, XV SO 2021
Is this your profile? Do login to access your certificatesXV SO 2021
DEVELOPMENT OF NEW COMBINATION STRATEGIES FOR FIRST-LINE CHEMOTHERAPY WITH SELECTIVE CYCLIN-DEPENDENT KINASES (CDK) 4/6 INHIBITORS IN COLORECTAL CANCER
XIV SO 2020
Development of new combination strategies for fist-line chemotherapy with selective cyclin-dependent kinases (CDK) 4/6 inhibitors in colorectal cancer and glioblastoma
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper